Larry Robbins sold $254M of CVS
director at CVS HEALTH Corp. 3,750,000 shares at an average of $67.65, traded May 2, 2025, filed May 6, 2025.
Score components
- +15RoleDirector
- +25Trade size$253.7M at market
- +10Share of holdings soldSold 31% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.8%, 3m -3.2%, 6m +20.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000905148-25-001466, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 2, 2025 | SOpen-market sale Common Stockindirect: Held by Glenview Investment Funds | -1,679,736 | $67.39 | $113M | 10,267,063 | May 6, 2025 |
| May 2, 2025 | SOpen-market sale Common Stockindirect: Held by Glenview Investment Funds | -222,556 | $68.38 | $15M | 10,044,507 | May 6, 2025 |
| May 2, 2025 | SOpen-market sale Common Stockindirect: Held by Glenview Investment Funds | -373,776 | $69.66 | $26M | 9,670,731 | May 6, 2025 |
| May 5, 2025 | SOpen-market sale Common Stockindirect: Held by Glenview Investment Funds | -1,226,933 | $67.37 | $83M | 8,443,798 | May 6, 2025 |
| May 5, 2025 | SOpen-market sale Common Stockindirect: Held by Glenview Investment Funds | -96,999 | $67.99 | $6.6M | 8,346,799 | May 6, 2025 |
| May 6, 2025 | SOpen-market sale Common Stockindirect: Held by Glenview Investment Funds | -150,000 | $66.67 | $10M | 8,196,799 | May 6, 2025 |
Related signals
Other insiders at CVS HEALTH Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 58Moderate | CVS HEALTH Corp | Larry Robbins director | $317M 3,372,000 shares | -41% | |
| 68Notable | CVS HEALTH Corp | Tilak Mandadi EVP, Chief Exp & Tech Officer | $6.2M 69,551 shares | -87% | |
| 27Weak | CVSbuy CVS HEALTH Corp | Steven H Nelson EVP and President, Aetna | $1,289 24 shares | - | |
| 25Weak | CVSbuy CVS HEALTH Corp | Heidi B Capozzi EVP and Chief People Officer | $4,589 80 shares | +1600% | |
| 43Moderate | CVSsell CVS HEALTH Corp | Anne A. Finucane director | $533k 7,500 shares | -25% | |
| 28Weak | CVSbuy CVS HEALTH Corp | Guy P Sansone director | $100k 1,570 shares | +15% | |
| 28Weak | CVSsell CVS HEALTH Corp | James David Clark SVP, Cont & Chief Acct Officer | $498k 7,513 shares | -47% | |
| 50Moderate | CVSbuy CVS HEALTH Corp | Michael F Mahoney director | $2.0M 30,000 shares | +321% | |
| 69Notable | CVS HEALTH Corp | Michael F Mahoney director | $500k 9,181 shares | +5246% | |
| 48Moderate | CVS HEALTH Corp | Edward J Ludwig director | $54k 1,000 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.